BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12557375)

  • 1. [Study on the methods for virus epidemiology in epitope level].
    Lai D; Du Y; Du G; Chen W; Wang H
    Wei Sheng Wu Xue Bao; 2002 Jun; 42(3):331-4. PubMed ID: 12557375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epitope mapping of antigenic determinants of hepatitis C virus proteins by phage display].
    Rechkina EA; Denisova GF; Masalova OV; Lideman LF; Denisov DA; Lesnova EI; Ataullakhanov RI; Gur'ianova SV; Kushch AA
    Mol Biol (Mosk); 2006; 40(2):357-68. PubMed ID: 16637277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of HCV antigen epitopes from a random 15-peptide library by anti-HCV polycloral antibody].
    Ke S; Zhu JP; Wen XY; Zhao P; Shi M; He YH; Yao ZJ; Shen BF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):65-7. PubMed ID: 15132911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of the phage display technology for the identification of a hepatitis C virus NS4A epitope recognized early in the course of the disease.
    Ferrieu-Weisbuch C; Bettsworth F; Becquart L; Paranhos-Baccala G; Michel S; Arnaud M; Jolivet-Reynaud C
    J Virol Methods; 2006 Feb; 131(2):175-83. PubMed ID: 16183141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Core protein of hepatitis C virus expressed in transgenic mice is associated with the expression of Fas molecule].
    Tan W; Lang Z; Cong Y; Chen G; Miao J; Zhan M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):205-7. PubMed ID: 15617329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane.
    Hourioux C; Ait-Goughoulte M; Patient R; Fouquenet D; Arcanger-Doudet F; Brand D; Martin A; Roingeard P
    Cell Microbiol; 2007 Apr; 9(4):1014-27. PubMed ID: 17257269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncated hepatitis C virus core protein encoded in hepatocellular carcinomas.
    Yamaguchi R; Momosaki S; Gao G; Hsia CC; Kojiro M; Scudamore C; Tabor E
    Int J Mol Med; 2004 Dec; 14(6):1097-100. PubMed ID: 15547681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core.
    Jackel-Cram C; Babiuk LA; Liu Q
    J Hepatol; 2007 Jun; 46(6):999-1008. PubMed ID: 17188392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope mapping of Mycoplasma hyopneumoniae using phage displayed peptide libraries and the immune responses of the selected phagotopes.
    Yang WJ; Lai JF; Peng KC; Chiang HJ; Weng CN; Shiuan D
    J Immunol Methods; 2005 Sep; 304(1-2):15-29. PubMed ID: 16054642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8.
    Hoshida Y; Kato N; Yoshida H; Wang Y; Tanaka M; Goto T; Otsuka M; Taniguchi H; Moriyama M; Imazeki F; Yokosuka O; Kawabe T; Shiratori Y; Omata M
    J Infect Dis; 2005 Jul; 192(2):266-75. PubMed ID: 15962221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Random fragment libraries displayed on filamentous phage.
    Wang LF; Yu M
    Methods Mol Biol; 1996; 66():269-85. PubMed ID: 8959722
    [No Abstract]   [Full Text] [Related]  

  • 14. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation.
    Abid K; Pazienza V; de Gottardi A; Rubbia-Brandt L; Conne B; Pugnale P; Rossi C; Mangia A; Negro F
    J Hepatol; 2005 May; 42(5):744-51. PubMed ID: 15826725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nucleotide sequence variation detection system for the core region of hepatitis C virus-1b.
    Okamoto K; Akuta N; Kumada H; Kobayashi M; Matsuo Y; Tazawa H
    J Virol Methods; 2007 Apr; 141(1):1-6. PubMed ID: 17184852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for construction of gene fragment library to searching epitopes.
    Kawamura M; Shibata H; Kamada H; Okamoto T; Mukai Y; Sugita T; Abe Y; Imai S; Nomura T; Nagano K; Mayumi T; Nakagawa S; Tsutsumi Y; Tsunoda SI
    Biochem Biophys Res Commun; 2006 Jul; 346(1):198-204. PubMed ID: 16759645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes.
    Grollo L; Torresi J; Drummer H; Zeng W; Williamson N; Jackson DC
    Antivir Ther; 2006; 11(8):1005-14. PubMed ID: 17302370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel protein binding to hepatitis C virus core protein.
    Chen YR; Chen TY; Zhang SL; Lin SM; Zhao YR; Ye F; Zhang X; Shi L; Dang SS; Liu M
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1300-4. PubMed ID: 19486448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
    Guo HZ; Wang WL; Wang T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):325-7. PubMed ID: 15193229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a better resolution of hepatitis C virus variants: CLIP sequencing of an HCV core fragment and automated assignment of genotypes and subtypes.
    Ross RS; Viazov S; Wolters B; Roggendorf M
    J Virol Methods; 2008 Mar; 148(1-2):25-33. PubMed ID: 18053586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.